Status:
COMPLETED
Administration of a Bitter-Tasting Medication: Comparison Between the Rx Medibottle and the Oral Syringe
Lead Sponsor:
Bronx-Lebanon Hospital Center Health Care System
Conditions:
Infant Acceptance of Medication
Eligibility:
All Genders
2-24 years
Phase:
NA
Brief Summary
Hypothesis: The Rx medibottle is more effective than the oral syringe when giving infants less than 2 years of age a bitter-tasting medication (prednisolone syrup). Summary: Infants who were admitted...
Detailed Description
The ability to deliver drugs to infants and children safely and accurately has long been of concern to pediatricians and caregivers. Calibrated oral syringes are accurate in measuring and delivering t...
Eligibility Criteria
Inclusion
- Admitted to the pediatric inpatient unit
- Stable condition
- Bottle fed
- Less than 2 years
- Receiving prednisolone syrup (15 mg/5 ml)
Exclusion
- Breast fed
- Greater than 2 years
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00634374
Start Date
January 1 2005
End Date
April 1 2006
Last Update
April 14 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bronx-Lebanon Hospital Center
The Bronx, New York, United States, 10457